Cargando…
Imaging Hepatocellular Carcinoma With (68)Ga-Citrate PET: First Clinical Experience
While cross-sectional imaging with computed tomography (CT) and magnetic resonance imaging is the primary method for diagnosing hepatocellular carcinoma (HCC), they provide little biological insight into this molecularly heterogeneous disease. Nuclear imaging tools that can detect molecular subsets...
Autores principales: | Mari Aparici, Carina, Behr, Spencer C., Seo, Youngho, Kelley, R. Kate, Corvera, Carlos, Gao, Kenneth T., Aggarwal, Rahul, Evans, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598799/ https://www.ncbi.nlm.nih.gov/pubmed/28893116 http://dx.doi.org/10.1177/1536012117723256 |
Ejemplares similares
-
Preparation and Quality Control of (68)Ga-Citrate for PET Applications
por: Aghanejad, Ayuob, et al.
Publicado: (2015) -
Pulmonary large cell neuroendocrine carcinoma (LCNEC) with confirmed liver metastases negative on (18)F-FDG and (68)Ga-DOTATATE PET
por: Ninatti, Gaia, et al.
Publicado: (2020) -
A Comparative (68)Ga-Citrate and (68)Ga-Chloride PET/CT Imaging of Staphylococcus aureus Osteomyelitis in the Rat Tibia
por: Lankinen, Petteri, et al.
Publicado: (2018) -
(68)Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors
por: Duan, Heying, et al.
Publicado: (2021) -
Potential usefulness of (68)Ga-citrate PET/CT in detecting infected lower limb prostheses
por: Tseng, Jing-Ren, et al.
Publicado: (2019)